Evaluation of predictive markers of glitazone efficacy in diabetic patients - pilot study
Phase of Trial: Phase II
Latest Information Update: 28 Jan 2009
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 Jan 2009 Planned patient numbers amended from 30 to 12 as reported by ClinicalTrials.gov.
- 28 Jan 2009 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.